AIDS Treatment News Issue #378, March 8, 2002
John S. James
The recent Retroviruses conference in Seattle reported more progress in AIDS research than perhaps any conference in the last few years. But the potential new drugs and research findings are still in early stages, and include some contradictory or confusing results. Experimental treatments may look good in early human tests but may or may not prove safe and effective for long-term use.
Here is an overview on lipoatrophy -- fat wasting -- a problem our readers have asked about. In future issues we expect to cover new drugs, treatment interruption, other lipodystrophy and drug side effects, and many other topics.
Note: the '-M', '-T', or '-W' in the abstract numbers in this conference just means that the presentation was a poster on Monday, Tuesday, or Wednesday. 'LB' in the abstract name means Late Breaker -- new research results that could not be submitted by the regular deadline but were considered important enough to be accepted anyway.
Other Retroviruses Conference Information
A one-hour telephone recording of an expert summary, organized by HIVandHepatitis.com, is available toll-free at 800-428-6051; when asked for an ID number, enter 227184 for this recording. You will be asked for your name, affiliation, and telephone number. This is a formality; you can say anything, even that you don't want to give the information, and the process will still go forward.
In some cities local AIDS service organizations are presenting programs with expert speakers who review conference highlights. In New York, for example, the National AIDS Treatment Advocacy Project will have a one-day update Saturday April 6, on the Retroviruses conference and on HIV/Hepatitis C co-infection. Advance registration is required due to building security; to register, call NATAP during business hours at either 888-26-NATAP, or 212-219- 0106. For other programs, check with service organizations in your area.
For in-depth information, see "Retroviruses Conference Web Coverage" in this issue.
020308
ATN37801
Copyright © 2002 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .